“We would like to inform you that the company has received a ‘no negative observations’ observation letter from BSE Limited (“BSE”) on December 4, 2025,” Dabur said in a filing with the regulator.
A BSE observation letter is a formal document issued to a listed company, usually in relation to a major corporate action such as a merger, amalgamation or restructuring, stating the stock exchange’s evaluation and ‘no adverse comments’ on the proposed arrangement, allowing the company to proceed to the next regulatory step.
“The Scheme remains subject to various statutory and regulatory approvals and from the respective shareholders and creditors of the companies involved in the Scheme, as may be required,” Dabur said.
Dabur had acquired a majority stake in Sesa Care in October 2024 and a full merger plan for Sesa Care into Dabur was approved by the board in May 2025.
Sesa is a leading brand in the Ayurvedic hair care market with strong brand equity.
#Dabur #receives #negative #comments #BSE #Sesa #Care #merger